News
Press Releases
Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of the Carillon Mitral Contour System® September 29, 2020
Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation September 2, 2020
Additional Press Releases
REDUCE FMR Study Shows Cardiac Dimensions’ Carillon System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure September 12, 2019
Cardiac Dimensions Announces DRG Reimbursement Code for Carillon Mitral Contour System® in Germany October 18, 2018
We’ve noticed some new faces so let us reintroduce ourselves! We're a leader in the development of minimally invasive treatments to address #heartfailure and related #cardiovascular conditions. We're reshaping the course of heart failure with the Carillon Mitral Contour System®. https://t.co/v6Ht2vbLxE
In continuing our celebration of #NationalHeartHealth Month, we hope you’ll join the #OurHearts Movement. This movement not only encourages but also motivates everyone to adopt heart-healthy behaviors. Get involved here: https://t.co/tapUPhytjO https://t.co/hEdsnpyhuR

This #BlackHistoryMonth, we celebrate the achievements and contributions made by African Americans, but also acknowledge the health inequities these communities face.
#Healthcare https://t.co/LYeJh2ySzJ
